#52026M12320EU merger notice for Armira and TA Associates acquisition of Intersurgical
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice opens EU merger review of Armira and TA Associates’ planned joint acquisition of Intersurgical, a medical device company focused on respiratory support products used in hospitals and home care. The Commission says the deal may qualify for the simplified merger procedure, which is used for transactions that appear unlikely to raise competition concerns. Competitors, customers, suppliers, and other interested parties have 10 days from publication to send comments to the Commission, quoting case M.12320.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- The Commission has received notice of Armira and TA Associates’ planned joint acquisition of Intersurgical.
- The transaction is being considered as a candidate for the EU simplified merger review process.
- Interested third parties have 10 days from publication to submit comments to the Commission.
Obligations
What this law requires
Interested parties that submit observations on the proposed concentration must send their comments to the European Commission within 10 days of publication and quote case M.12320.